1. Medtech Insight
  3. >>Diagnostics

IVD Earnings Roundup: Roche's Diabetes Division Takes A Dip; Quest Diagnostics; bioMérieux; Danaher

 
• By Catherine Longworth

Roche's diabetes business continues to struggle as third quarter results show sales in the division dipped by 3%, while Quest Diagnostics' bottom line took a hit from special charges. Meanwhile, bioMérieux said third-quarter revenues increased by 7%; Danaher is finalizing its acquisition of Cepheid.

Roche reported revenue of CHF8.4bn for its diagnostics division for the first nine months of 2016, a 7% increase from the same period last year. The Swiss group attributed the growth to particularly strong double-digit diagnostic sales increases in Asia-Pacific (+17%) and Latin America (+21%). However, in developed markets, diagnostics sales floundered with North America (+4%) and Europe (+2%).

Roche saw another downward trend for its diabetes business with sales decreasing by 3%. Roche said sales continued to be...

More from In Vitro Diagnostics

Thena Capital’s New Fund Up And Running With £1M Investment In Plexāā’s Breast Cancer Device

 
• By Natasha Barrow

Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.

Milner Pitch Day: Multiomic Pathology, Microcancer Avatars And Cell Morphology Intelligence

 
• By Natasha Barrow

The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.

Dxcover Launches US Operations With New Headquarters In Tennessee

 
• By Natasha Barrow

Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee.

Newborn Screening Tests Among FDA Classifications

 
• By Elizabeth Orr

The US FDA has announced classifications for five device types, including four diagnostics as well as a hand cream to protect healthcare workers exposed to radiation. Two of the products are newborn screening tests.

More from Diagnostics